Loading...

Major Indexes

Financial Statements

Abbott Laboratories

Abbott Laboratories (ABT)

$79.34
4.78 (+6.41%)

Income Statement

Download ABT income statement Download ABT income statement
Year 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009
Earnings Per Share Basic 3.712.983.033.761.641.502.940.940.271.342.07
Net Profit Margin 0.190.130.120.150.120.110.220.070.020.080.12
Earnings Per Share Diluted 3.692.963.013.721.621.492.920.940.271.332.06
Revenue 30,764.7135,166.7238,851.2639,873.9121,848.0020,247.0020,405.0020,853.0027,390.0030,578.0031,904.00
Weighted Average Shares Outstanding 1,546.741,546.401,557.641,575.381,558.001,516.001,496.001,477.001,740.001,758.001,768.00
Gross Profit 17,555.3820,501.5323,310.6824,754.1911,808.0011,029.0011,658.0011,829.0015,053.0017,872.0018,673.00
Weighted Average Shares Outstanding (Diluted) 1,546.981,556.021,567.391,591.841,574.001,527.001,506.001,483.001,749.001,770.001,781.00
Sales, General and Administrative Expense 8,405.9010,376.3212,756.8212,059.506,936.006,530.006,785.006,672.009,117.009,744.009,765.00
Dividend per Share 0.000.000.000.000.000.000.000.000.000.000.00
Operating Income 6,235.746,087.585,751.958,084.522,629.002,599.002,867.003,185.001,726.003,650.004,532.00
Gross Margin 0.570.580.600.620.540.540.570.570.550.580.59
Earnings before Tax 7,193.774,626.175,198.646,262.612,521.002,518.003,183.001,413.002,231.002,873.004,077.00
EBITDA Margin 0.320.250.230.270.200.200.210.230.210.230.24
Net Income 5,745.844,626.174,728.455,962.922,576.002,284.004,423.001,400.00477.002,368.003,687.00
EBIT Margin 0.250.170.150.200.120.130.140.150.060.120.14
Net Income - Discounted ops -----------
Profit Margin 0.190.130.120.150.120.110.220.070.020.080.12
Preferred Dividends -----------
Free Cash Flow margin 0.000.000.000.000.000.000.000.000.000.000.00
R&D Expenses 2,743.733,724.424,129.414,322.181,452.001,345.001,405.001,422.002,235.002,300.002,440.00
Interest Expense 519.66553.13530.14592.40157.00150.00163.00431.00904.00826.00670.00
Earnings Before Tax Margin 0.230.130.130.160.120.120.160.070.080.090.13
Consolidated Income 5,745.844,626.174,728.455,962.922,576.002,284.004,423.001,400.00477.002,368.003,687.00
EBIT 7,713.436,087.585,751.958,084.522,629.002,599.002,867.003,185.001,726.003,650.004,532.00
EBITDA 9,802.948,711.898,795.8410,867.724,348.004,147.004,339.004,703.005,659.006,960.007,546.00
Income Tax Expense 1,447.941,086.66470.19299.69138.00797.00577.00350.001,878.00539.00390.00
Operating Expenses 11,319.6414,100.7516,886.2316,381.688,388.007,875.008,190.008,094.0011,352.0012,044.0012,205.00
Cost of Revenue 13,209.3314,665.1915,540.5815,119.7210,040.009,218.008,747.009,024.0012,337.0012,706.0013,231.00
Net Income Com 5,745.844,626.174,728.455,962.922,576.002,284.004,423.001,400.00477.002,368.003,687.00
Net Income - Non-Controlling int -----------

Balance Sheet Statement

Download ABT income statement Download ABT income statement
Year 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009
Total current liabilities 13,049.4917,262.4315,480.2313,280.189,507.0010,532.009,186.006,660.008,912.009,012.0010,863.00
Other Liabilities 6,579.33-2,987.72-2,614.23-2,893.95-2,425.00-1,484.00-2,639.00-2,107.00-415.007,003.008,739.00
Long-term debt 11,266.2912,523.5212,039.8218,085.303,388.003,408.005,871.0020,681.0027,210.0019,359.0016,661.00
Cash and cash equivalents 9,932.053,648.376,812.8210,802.163,475.004,063.005,001.0018,620.009,407.003,844.003,860.00
Total debt 16,455.9114,568.4913,066.7218,394.133,397.003,463.005,874.0020,684.0027,718.0019,366.0017,938.00
Cash and short-term investments 9,932.055,451.458,097.3615,173.983,501.004,460.006,125.0018,775.009,610.004,164.004,140.00
Deferred revenue ---------259.00294.00
Inventories 3,264.883,188.733,284.253,792.312,693.002,643.002,599.002,434.003,601.003,796.004,316.00
Tax Liabilities 442.141,307.72514.95655.42175.00270.00430.00188.00309.00305.00226.00
Goodwill and Intangible Assets 19,492.1628,081.7125,695.0224,362.4115,507.0016,265.0015,200.0012,222.0045,493.0042,196.0040,225.00
Deposit Liabilities -----------
Tax assets 3,387.363,076.052,700.542,986.222,528.001,705.004,383.002,263.001,944.001,868.003,079.00
Total non-current liabilities 16,344.7422,799.4222,971.0630,127.7510,700.0010,701.0013,489.0027,575.0036,856.0020,634.0017,197.00
Total current assets 23,313.8922,317.5323,768.7731,322.5819,247.0015,261.0014,155.0026,776.0020,147.0014,632.0015,667.00
Total liabilities 29,394.2337,074.1335,837.0640,513.9817,782.0019,749.0020,036.0032,128.0045,353.0036,649.0036,799.00
Payables 1,280.541,535.761,721.131,796.991,026.001,064.001,081.001,178.002,402.002,975.003,252.00
Other comprehensive income 854.07----------
Short-term investments -1,803.081,284.544,371.8226.00397.001,124.00155.00203.00320.00280.00
Retained earnings (deficit) 17,342.6918,927.1020,907.3624,151.0021,979.0022,874.0025,757.0025,565.0023,978.0024,560.0025,847.00
Property, Plant & Equipment Net 7,619.497,970.967,873.958,063.055,905.005,935.005,730.005,705.007,607.007,563.008,038.00
Total non-current assets 29,267.7337,144.7436,508.1235,912.3623,706.0026,014.0027,092.0025,890.0056,103.0052,541.0052,220.00
Other Assets 3,575.03----------
Net Debt 6,523.8710,920.126,253.907,591.96-78.00-600.00873.002,064.0018,311.0015,522.0014,078.00
Investments 1,132.872,105.131,662.764,645.4226.00626.005,165.003,102.001,086.00531.001,163.00
Total shareholders equity 23,187.4022,388.1324,439.8326,720.9625,171.0021,526.0021,211.0020,538.0030,897.0030,524.0031,088.00
Total assets 52,581.6259,462.2760,276.8967,234.9442,953.0041,275.0041,247.0052,666.0076,250.0067,173.0067,887.00
Long-term investments 1,132.87302.05378.23273.60-229.004,041.002,947.00883.00211.00883.00
Receivables 6,541.947,184.037,683.927,612.863,986.003,586.003,418.003,248.005,249.005,182.005,425.00
Short-term debt 5,189.622,044.971,026.90308.829.0055.003.003.00508.007.001,277.00

Cash Flow Statement

Download ABT income statement Download ABT income statement
Year 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009
Insurance (repayment) of debt -----------
Net Cash/Marketcap -0.00----------
Insurance (buybacks) of shares -----------
Depreciation & Amortization 2,089.512,624.303,043.892,783.211,719.001,548.001,472.001,518.003,933.003,310.003,014.00
Dividend payments -2,414.46-2,671.47-2,938.10-3,182.81-882.00-1,342.00-1,443.00-1,539.00-1,849.00-1,974.00-2,270.00
Operating Cash Flow 7,275.168,735.988,970.089,314.403,324.003,675.002,966.003,203.005,570.006,300.006,136.00
Acquisitions and disposals -2,370.63-9,433.24-672.50-1,227.47-580.00-3,317.00-235.00-80.00-17,183.00--
Free Cash Flow 6,186.117,720.917,478.587,519.112,179.002,598.001,856.002,082.004,435.004,906.004,498.00
Net cash flow / Change in cash 4,697.32-5,160.973,164.4510,802.16-7,327.00588.00938.0013,619.00-9,213.00-5,563.0016.00
Effect of forex changes on cash 118.85-620.89-43.0140.14-26.00-143.00-198.00-483.00116.00-116.00-16.00
Financing Cash Flow 1,002.02-1,087.74-6,023.45716.09-6,696.00-2,742.00-2,236.0011,147.00-5,281.00-10,391.00-4,289.00
Investment purchases and sales -232.66-1,672.76-5,186.99-14,361.89-11,669.00-3,702.00-7,170.00-3,345.00-327.00-369.00-800.00
Capital Expenditure -1,089.051,015.081,491.501,795.291,145.001,077.001,110.001,121.001,135.001,394.001,638.00
Stock-based compensation 366.36387.18382.60433.11262.00246.00292.00310.00406.00477.00519.00
Investing Cash Flow -----------

Retained Earning Schedule

Year 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009
Retained Earnings (Previous Year) -17,34318,92720,90724,15121,97922,87425,75725,56523,97824,560
Net Income 5,7464,6264,7285,9632,5762,2844,4231,4004772,3683,687
Stock Dividends 14,011-370190464-3,866-47-97-53-215188-130
Dividend Paid -2,414-2,671-2,938-3,183-882-1,342-1,443-1,539-1,849-1,974-2,270
Retained Earnings 17,34318,92720,90724,15121,97922,87425,75725,56523,97824,56025,847

PPE Schedule

Year 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009
Gross PPE -7,6197,9717,8748,0635,9055,9355,7305,7057,6077,563
Annual Depreciation 8,709-664-1,589-1,606-3,303-1,047-1,315-1,146767-1,438-1,163
Capital Expenditure -1,0891,0151,4921,7951,1451,0771,1101,1211,1351,3941,638
Net PPE 7,6197,9717,8748,0635,9055,9355,7305,7057,6077,5638,038

Intangible and Goodwill Schedule

Year 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009
Intangible and Goodwill (Previous Year) -19,49228,08225,69524,36215,50716,26515,20012,22245,49342,196
New Purchases -233-1,673-5,187-14,362-11,669-3,702-7,170-3,345-327-369-800
Intangible and Goodwill 19,49228,08225,69524,36215,50716,26515,20012,22245,49342,19640,225

Abbott Laboratories income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Abbott Laboratories FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.